Evidence map›Paper›PMID 33535043›Full record

ArticleCell reports2021

The E protein-TCF1 axis controls γδ T cell development and effector fate.

Shawn P Fahl, Alejandra V Contreras, Anjali Verma, Xiang Qiu, Christelle Harly, Freddy Radtke, Juan Carlos Zúñiga-Pflücker, Cornelis Murre, Hai-Hui Xue, Jyoti Misra Sen and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Development of αβ and γδ T Cells in the Thymus and Methods of Analysis.International journal of molecular sciences · 2025
    Review
  5. HEB collaborates with TCR signaling to upregulatebioRxiv : the preprint server for biology · 2025
    Article
  6. HEB Restrains Effector Gene Expression during Early CD8Molecular and cellular biology · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. T cells in health and disease.Signal transduction and targeted therapy · 2023
    Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

Shawn P FahlBlood Cell Development and Function Program, Fox Chase Cancer Center, 333 Burholme Avenue, Philadelphia, PA 19111, USA.
Alejandra V ContrerasBlood Cell Development and Function Program, Fox Chase Cancer Center, 333 Burholme Avenue, Philadelphia, PA 19111, USA.
Anjali VermaNational Institute on Aging, National Institutes of Health, 251 Bayview Blvd., Baltimore, MD 21224, USA.
Xiang QiuNational Institute on Aging, National Institutes of Health, 251 Bayview Blvd., Baltimore, MD 21224, USA.
Christelle HarlyNational Cancer Institute, National Institutes of Health, Bethesda, MD 20184, USA.
Freddy RadtkeEcole Polytechnique Fédérale de Lausanne, School of Life Sciences, Swiss Institute for Experimental Cancer Research, Lausanne, Switzerland.
Juan Carlos Zúñiga-PflückerDepartment of Immunology, University of Toronto, Sunnybrook Research Institute, 2075 Bayview Ave., Toronto, ON M4N 3M5, Canada.
Cornelis MurreDepartment of Molecular Biology, University of California at San Diego, La Jolla, CA 92093, USA.
Hai-Hui XueCenter for Discovery and Innovation, Hackensack University Medical Center, Nutley, NJ 07110, USA.
Jyoti Misra SenNational Institute on Aging, National Institutes of Health, 251 Bayview Blvd., Baltimore, MD 21224, USA; Immunology Program, Department of Medicine, Johns Hopkins School of Medicine, Bayview Blvd., Baltimore, MD 21224, USA. Electronic address: jyoti-sen@nih.gov.
David L WiestBlood Cell Development and Function Program, Fox Chase Cancer Center, 333 Burholme Avenue, Philadelphia, PA 19111, USA. Electronic address: david.wiest@fccc.edu.
National Institutes of Health · USFox Chase Cancer Center · USÉcole Polytechnique Fédérale de Lausanne · CHHackensack University Medical Center · USSunnybrook Health Science Centre · CAUniversity of California San Diego · US

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Margaret von Mehren · 1985 to 2026
$138.8M
The role of TCR, ligand, and signal strength in human γδ T cell developmentP01AI102853 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI CORNELIS MURRE · 2014 to 2026
$26.3M
Tcf/Lef-b-catenin in T cell identity and cancerR01AI112579 · NIAID · UNIVERSITY OF IOWA · PI Hai-Hui Xue · 2015 to 2026
$5.4M
Tcf/Lef and B-catenin pathway in follicular helper T cellsR01AI121080 · NIAID · UNIVERSITY OF IOWA · PI Hai-Hui Xue · 2016 to 2026
$4.6M
Ezh2 regulates follicular helper T cell differentiationR01AI139874 · NIAID · UNIVERSITY OF IOWA · PI PENG, WEIQUN, XUE, HAI-HUI · 2018 to 2022
$2.4M
NCI NIH HHS P30 CA006927NIAID NIH HHS P01 AI102853NIAID NIH HHS R01 AI112579NIAID NIH HHS R01 AI121080NIAID NIH HHS R01 AI139874
6 · The paper itself

Abstract

TCF1 plays a critical role in T lineage commitment and the development of αβ lineage T cells, but its role in γδ T cell development remains poorly understood. Here, we reveal a regulatory axis where T cell receptor (TCR) signaling controls TCF1 expression through an E-protein-bound regulatory element in the Tcf7 locus, and this axis regulates both γδ T lineage commitment and effector fate. Indeed, the level of TCF1 expression plays an important role in setting the threshold for γδ T lineage commitment and modulates the ability of TCR signaling to influence effector fate adoption by γδ T lineage progenitors. This finding provides mechanistic insight into how TCR-mediated repression of E proteins promotes the development of γδ T cells and their adoption of the interleukin (IL)-17-producing effector fate. IL-17-producing γδ T cells have been implicated in cancer progression and in the pathogenesis of psoriasis and multiple sclerosis.

Indexed as

AnimalsCell DifferentiationHepatocyte Nuclear Factor 1-alphaHumansMiceModels, ImmunologicalReceptors, Antigen, T-Cell, gamma-deltaSignal TransductionHepatocyte Nuclear Factor 1-alphaHnf1a protein, mouseReceptors, Antigen, T-Cell, gamma-deltadevelopmentE proteinsinterleukin-17T cell receptor (TCR)TCF1TCR signalingγδ T cell

Identifiers

PMID33535043
PMCPMC7919611
OpenAlexW3127236296

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.